Article

CIBA Vision voluntarily recalls lotrafilcon B lenses

Duluth, GA-CIBA Vision Corp. has launched a voluntary trade-level recall of select lots of O2Optix (lotrafilcon B) contact lenses, distributed primarily in the United States, and in other countries excluding Japan.

Duluth, GA-CIBA Vision Corp. has launched a voluntary trade-level recall of select lots of O2Optix (lotrafilcon B) contact lenses, distributed primarily in the United States, and in other countries excluding Japan.

According to a statement, the company "[took] this action because we have identified that some lenses in these lots did not meet our standards for ion permeability, a material characteristic which contributes to lens movement on the eye. Some lenses with reduced ion permeability may cause persistent discomfort until the lens is removed, which could lead to corneal irritation for some wearers."

The CIBA Vision U.S. consumer Web site, http://www.us.cibavision.com/, offers users an apology for the current unavailability of O2Optix product. "This situation is due to a number of different factors including manufacturing capacity issues and a recent limited voluntary, trade-level recall from eye-care professional, distributor, and retailer inventories," according to the company's Web site.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
I. Paul Singh, MD, speaks about glaucoma treatment and successful ophthalmic / optometric comanagement at the 19th Annual Controversies in Modern Eye Care meeting
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
© 2025 MJH Life Sciences

All rights reserved.